J. Stevenson

M. Karsdal, C. Christiansen, I. Lambrinoudaki, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

PLASMA-CALCITONIN IN WOMEN

J. Kanis, T. Cundy, M. Kissin, 1978, The Lancet.

RELATIVE DEFICIENCY OF PLASMA-CALCITONIN IN NORMAL WOMEN

I. Macintyre, J. Stevenson, C. Hillyard, 1978, The Lancet.

Chemistry, physiology, and therapeutic applications of calcitonin.

I. Macintyre, J. Stevenson, I. Evans, 1980, Arthritis and rheumatism.

Effects in Postmenopausal Women of Natural and Synthetic Estrogens on Calcitonin and Calcium‐Regulating Hormone Secretion

M. Whitehead, G. Lane, J. Stevenson, 1982, Acta obstetricia et gynecologica Scandinavica. Supplement.

Interrelations of calcium-regulating hormones during normal pregnancy.

S. Campbell, M. Whitehead, G. Lane, 1981, British medical journal.

CALCITONIN AND THE CALCIUM-REGULATING HORMONES IN POSTMENOPAUSAL WOMEN: EFFECT OF OESTROGENS

M. Whitehead, I. Macintyre, J. Stevenson, 1981, The Lancet.

Osteoporosis and calcitonin deficiency.

J. Stevenson, M. White, G. Joplin, 1982, British medical journal.

KATACALCIN: A NEW PLASMA CALCIUM-LOWERING HORMONE

I. Macintyre, J. Stevenson, C. Hillyard, 1983, The Lancet.

Regulation of calcium‐regulating hormones by exogenous sex steroids in early postmenopause

S. Campbell, M. Whitehead, G. Lane, 1983, European journal of clinical investigation.

Racial differences in calcitonin and katacalcin

A. Ajdukiewicz, J. Stevenson, C. Myers, 1984, Calcified tissue international.

CALCITONIN GENE-RELATED PEPTIDE: POTENT VASODILATOR AND MAJOR PRODUCT OF CALCITONIN GENE

S. Wimalawansa, C. Self, S. Girgis, 1985, The Lancet.

Osteoporosis with hip fracture: changes in calcium regulating hormones

J. Stevenson, G. Abeyasekera, P. R. Allen, 1986, European journal of clinical investigation.

Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Heart Disease and Diabetes Risk Indicators in a Screened Cohort.

I. Godsland, F. Leyva, J. Stevenson, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Justification for the use of HRT in the long-term prevention of osteoporosis.

J. Stevenson, 2005, Maturitas.

Prevention Early After Menopause

J. Stevenson, 2004 .

Prevention Early After Menopause: Hormonal

J. Stevenson, N. Manassiev, 1998 .

Calcium and Bone Metabolism

T. Arnett, J. Stevenson, 1993 .

Which progestogen is more likely to increase the risk of fatal myocardial infarction: a combination of epidemiological and trial evidence.

F. al-Azzawi, J. Stevenson, John R. Thompson, 2006, Maturitas.

Calcitonin gene peptides: the diagnostic value of measurement in medullary thyroid carcinoma.

S. Girgis, I. Macintyre, J. Stevenson, 1987, Henry Ford Hospital medical journal.

Coronary heart disease and menopause management: the swinging pendulum of HRT.

H. Hodis, R. Lobo, J. Pickar, 2009, Atherosclerosis.

Postmenopausal osteoporosis.

M. Whitehead, J. Stevenson, 1982, British medical journal.

Hormone replacement therapy: where we stand in Europe.

G. Rosano, T. Simon, G. Mercuro, 2001, European heart journal.

Effects of HRT on Metabolic Risk Factors for Cardiovascular Disease

J. Stevenson, 1994 .

Postmenopausal oestrogen and cardioprotection

P. Hardiman, M. Whitehead, J. Stevenson, 1991, The Lancet.

Risks and benefits of hormone therapy: has medical dogma now been overturned?

S. Shapiro, H. Burger, A. Pines, 2014, Climacteric : the journal of the International Menopause Society.

Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy

J. Williamson, M. Rees, J. Stevenson, 2003, The journal of the British Menopause Society.

Managing the menopause: BMS Council Consensus statement on HRT

J. Williamson, M. Rees, J. Stevenson, 2004, The journal of the British Menopause Society.

HRT, osteoporosis and regulatory authorities Quis custodiet ipsos custodes?

J. Stevenson, 2006, Human reproduction.

Role of oestrogen in the development of osteoporosis

T. Hillard, J. Stevenson, 2007, Calcified Tissue International.

Hormone replacement therapy: Review, update, and remaining questions after the women’s health initiative study

J. Stevenson, 2004, Current osteoporosis reports.

Hormone replacement therapy

M. Whitehead, J. Stevenson, 2002, BMJ : British Medical Journal.

Continuation rates for oral contraceptives and hormone replacement therapy. The ESHRE Capri Workshop Group.

P. Crosignani, E. Diczfalusy, B. Tarlatzis, 2000, Human reproduction.

Relevance of osteoporosis in women with fracture of the femoral neck

M. Whitehead, J. Stevenson, 1984 .

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

M. Whitehead, B. Lees, J. Stevenson, 1990, The Lancet.

Metabolic effects of the menopause and oestrogen replacement.

J. Stevenson, 1996, Bailliere's clinical obstetrics and gynaecology.

Effects of oestrogen‐only and oestrogen–progestogen replacement therapy upon circulating angiotensin I‐converting enzyme activity in postmenopausal women

M. Whitehead, J. Stevenson, A. Proudler, 2003, Clinical endocrinology.

Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women

I. Fogelman, A.I.H. Ahmed, J. Rymer, 1995, The Lancet.

Obesity and risk of coronary heart disease in women.

J. Manson, W. Willett, F. Speizer, 1990, The New England journal of medicine.

Effects of gender, age and menopausal status on serum apolipoprotein concentrations

I. Godsland, D. Johnston, J. Stevenson, 2016, Clinical endocrinology.

HRT and the primary prevention of cardiovascular disease.

J. Stevenson, 2007, Maturitas.

Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP Pilot Study.

M. Flather, P. Collins, B. Lees, 2006, European heart journal.

Cardiovascular effects of oestrogens

J. Stevenson, 2000, The Journal of Steroid Biochemistry and Molecular Biology.

HRT and the Secondary Prevention of Coronary Heart Disease

J. Stevenson, 1997 .

Is there a menopausal metabolic syndrome?

I. Godsland, J. Stevenson, C. Spencer, 1997, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Conflicts of interest, smoke and mirrors

J. Stevenson, 2015, Climacteric : the journal of the International Menopause Society.

The Influence of Sex Steroids on Affairs of the Heart

J. Stevenson, M. Gerval, 2014 .

Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.

E. Kahler, J. Stevenson, T. Pertyński, 2010, Maturitas.

Hormone replacement therapy and cardiovascular disease revisited

J. Stevenson, 2009, Menopause international.

HRT and cardiovascular disease.

J. Stevenson, 2009, Best practice & research. Clinical obstetrics & gynaecology.

Type and route of estrogen administration

J. Stevenson, 2009, Climacteric : the journal of the International Menopause Society.

The metabolic basis for the effects of HRT on coronary heart disease

J. Stevenson, 2004, Endocrine.

Hormone therapy and heart disease

J. Stevenson, 2002, The Lancet.

17β-Estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women

B. Lees, J. Stevenson, P. Teter, 2001 .

17beta-estradiol (1 mg/day) continuously combined with dydrogesterone (5, 10 or 20 mg/day) increases bone mineral density in postmenopausal women.

B. Lees, J. Stevenson, P. Teter, 2001, Maturitas.

Will heartburn break your leg?

J. Stevenson, 2012, Maturitas.

Osteoporosis management in patients with breast cancer: EMAS position statement.

I. Lambrinoudaki, Y. T. van der Schouw, T. Simoncini, 2017, Maturitas.

Intranasal calcitonin and plasma calcium concentrations

J. Stevenson, 1985, British medical journal.

Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis.

I. Lambrinoudaki, D. Goulis, E. Tsiridis, 2019, European journal of endocrinology.

The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis.

I. Lambrinoudaki, D. Goulis, I. Godsland, 2017, Maturitas.

Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement.

I. Lambrinoudaki, D. Goulis, G. Mintziori, 2017, Maturitas.

Mechanisms whereby oestrogens influence arterial health.

J. Stevenson, 1996, European journal of obstetrics, gynecology, and reproductive biology.

A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update

C. Cooper, R. Francis, D. Torgerson, 1998, Journal of internal medicine.

Prevention of osteoporosis: one step forward, two steps back

J. Stevenson, 2011, Menopause international.

Use of Pro-Gest cream in postmenopausal women

J. Stevenson, D. Purdie, 1998, The Lancet.

Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis

M. Whitehead, L. Banks, B. Lees, 1996, Calcified Tissue International.

Is It Safe to Prevent and Treat Postmenopausal Osteoporosis

T. Stevenson, J. Stevenson, 2014 .

Menopause-associated risk of cardiovascular disease

I. Lambrinoudaki, D. Goulis, J. Stevenson, 2022, Endocrine connections.

Is there a role for menopausal hormone therapy in a woman with increased lipoprotein (a) concentrations?

J. Stevenson, P. Anagnostis, 2019, Journal of clinical lipidology.

The WHI: the effect of hormone replacement therapy on fracture prevention

T. D. de Villiers, J. Stevenson, 2012, Climacteric : the journal of the International Menopause Society.

Hormone replacement therapy and cardiovascular disease

J. Stevenson, 2005 .

Helping women make the right HRT choice

J. Stevenson, 2005 .

Premature Ovarian Insufficiency: Practical Management Approaches

N. Panay, J. Stevenson, S. Tsiligiannis, 2019, Menstrual Cycle Related Disorders.

Premature Ovarian Insufficiency and Long-Term Health Consequences.

N. Panay, J. Stevenson, S. Tsiligiannis, 2019, Current vascular pharmacology.

Early menopause is associated with increased risk of arterial hypertension: A systematic review and meta-analysis.

I. Lambrinoudaki, D. Goulis, J. Bosdou, 2020, Maturitas.

HRT and breast cancer risk: a realistic perspective

H. Hodis, R. Lobo, J. Pickar, 2011, Climacteric.

Menopause and Age-Related General Health Risk: A Woman’s Heart Needs Her Hormones

J. Stevenson, A. Czyżyk, 2019, Postmenopausal Diseases and Disorders.

Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings: authors’ response

S. Shapiro, H. Burger, A. Mueck, 2013, Journal of Family Planning and Reproductive Health Care.

Bisphosphonates and atypical femoral shaft fractures.

J. Stevenson, 2011, The New England journal of medicine.

If only WHI was done well

H. Hodis, R. Lobo, J. Pickar, 2010, BMJ : British Medical Journal.

Late prevention of hip fractures with hormone replacement therapy

J. Stevenson, 2005, Osteoporosis International.

Elevated Serum Lipoprotein(a) Levels in Young Women With Endometriosis

D. Edmonds, J. Stevenson, D. Crook, 1997 .

EMAS position statement: Predictors of premature and early natural menopause.

I. Lambrinoudaki, D. Goulis, P. Chedraui, 2019, Maturitas.

Bone-density measurement

J. Kanis, D. Reid, C. Christiansen, 1992, The Lancet.

Preventing oesteoporosis

J. Stevenson, M. Marsh, 1991 .

Determinants of bone density in normal women: risk factors for future osteoporosis?

B. Lees, J. Stevenson, M. Cust, 1989, BMJ.

Bone and Calcium Metabolism

W. Fraser, J. Stevenson, K. Colston, 2013 .

Alternatives to HRT in prevention and treatment.

J. Stevenson, M. Marsh, 1993, Bailliere's clinical rheumatology.

Prevention of Osteoporosis

J. Stevenson, M. Ellerington, 1992 .

Prevention and treatment of osteoporosis in women

J. Stevenson, 2018, Post reproductive health.

Authors gave distorted view through selective citation

M. Whitehead, J. Stevenson, John Stevenson, 1996, BMJ.

Role of bone density measurement in the management of sarcoidosis

J. Stevenson, K. Maclaran, 2012 .

CALCITONIN FOR PREVENTION OF POSTMENOPAUSAL BONE LOSS

S. Wimalawansa, M. Whitehead, L. Banks, 1988, The Lancet.

Calcitonin in the prevention and treatment of osteoporosis

J. Stevenson, 1993 .

Calcitonin gene peptides and bone metabolism

T. Arnett, J. Stevenson, D. Macdonald, 1990 .

Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.

I. Lambrinoudaki, S. Kehoe, T. Simoncini, 2017, Maturitas.

Menopause and diabetes: EMAS clinical guide.

I. Lambrinoudaki, D. Goulis, P. Chedraui, 2018, Maturitas.

Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, London.

J. Reginster, J. Kaufman, M. Dören, 1998, Climacteric : the journal of the International Menopause Society.

Insulin resistance: syndrome or tendency?

I. Godsland, J. Stevenson, 1995, The Lancet.

Comparison of transdermal and oral estrogen‐progestin replacement therapy: Effects on serum lipids and lipoproteins

V. Wynn, M. Whitehead, J. Stevenson, 1992 .

Hormone replacement therapy and the cardiovascular system. Nonlipid effects.

I. Godsland, M. Whitehead, P. Collins, 1994, Drugs.

Hormone replacement therapy with dydrogesterone and 17β‐oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up

I. Godsland, J. Stevenson, D. Crook, 1997 .

Progestogens, lipid metabolism and hormone replacement therapy

J. Stevenson, D. Crook, 1991, British journal of obstetrics and gynaecology.

Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors.

R. Shaw, J. Stevenson, M. Worthington, 1989, Hormone research.

Mechanisms of Estrogen Action on the Cardiovascular System

J. Stevenson, 2001 .

Various actions of oestrogens on the vascular system.

J. Stevenson, John C. Stevenson, 1998, Maturitas.

Physiological hyperinsulinemia is not associated with alterations in venous plasma levels of endothelin-1 in healthy individuals.

F. Leyva, J. Stevenson, C. Wingrove, 1997, Metabolism: clinical and experimental.

Randomized trial of effect of transdermal continuous combined hormone replacement therapy on cardiovascular risk markers

M. Whitehead, J. Stevenson, A. Proudler, 2004, British journal of haematology.

Metabolic effects of hormone replacement therapy

J. Stevenson, 2004, The journal of the British Menopause Society.

Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide.

I. Lambrinoudaki, D. Goulis, P. Chedraui, 2018, Maturitas.

Bisphosphonate drug holidays – when, why and for how long?

J. Stevenson, P. Anagnostis, 2015, Climacteric : the journal of the International Menopause Society.

HRT for the Primary Prevention of Coronary Heart Disease

J. Stevenson, 2019, ISGE Series.

Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes risk in the first follow‐up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC‐1)

I. Godsland, F. Leyva, J. Stevenson, 1998 .

A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.

I. Godsland, J. Stevenson, D. Crook, 1993, American journal of obstetrics and gynecology.

Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions.

I. Godsland, D. Johnston, J. Stevenson, 2015, Maturitas.

The Effect of Menopause and HRT on Coronary Heart Disease

J. Stevenson, 2018 .

What constitutes healthy eating for the heart?

J. Stevenson, 2013, Maturitas.

Cardiovascular disease in women

J. Stevenson, 2008, Menopause international.

Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women.

J. Rymer, J. Stevenson, D. Crook, 1993, Acta endocrinologica.

Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid.

M. Seed, J. Stevenson, D. Crook, 1992, Atherosclerosis.

Influence of age and menopause on serum lipids and lipoproteins in healthy women.

I. Godsland, J. Stevenson, D. Crook, 1993, Atherosclerosis.

Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high‐density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two‐year, randomized, double‐blind, placebo‐controlled trial

I. Godsland, J. Stevenson, D. Crook, 2020, Clinical endocrinology.

1 and 2 mg 17β-estradiol combined with sequential dydrogesterone have similar effects on the serum lipid profile of postmenopausal women

M. Gelfand, J. Stevenson, J. Rioux, 2005, Climacteric : the journal of the International Menopause Society.

A randomised comparison of the effects of oral versus transdermal 17β‐oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels

M. Whitehead, J. Stevenson, D. Crook, 1999, British journal of obstetrics and gynaecology.

Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease.

S. Anker, I. Godsland, A. Coats, 2000, European heart journal.

Human calcitonin gene related peptide: a potent endogenous vasodilator in man.

H. Morris, A. Struthers, M. Brown, 1986, Clinical science.

17 beta-Oestradiol inhibits stimulated endothelin release in human vascular endothelial cells.

J. Stevenson, C. Wingrove, 1997, European journal of endocrinology.

Effects of equine oestrogens on markers of vasoactive function in human coronary artery endothelial cells

E. Garr, J. Pickar, J. Stevenson, 1999, Molecular and Cellular Endocrinology.

Bombesin: action on gut hormones and calcium in man.

T. Adrian, S. Bloom, R. Jung, 1982, The Journal of clinical endocrinology and metabolism.

Osteoporosis and cardiovascular disease in women: converging paths?

J. Stevenson, 1990, The Lancet.

Circulating CGRP comes from the perivascular nerves.

M. Zaidi, S. Girgis, I. Macintyre, 1985, European journal of pharmacology.

Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy.

I. Fogelman, A. Rodin, J. Stevenson, 1989, The Journal of clinical endocrinology and metabolism.

Pharmacology and Therapeutic Use of Calcitonin

J. Stevenson, I. Evans, 1981, Drugs.

Mineral Needs of the Fetus

J. Stevenson, 1983 .

Regulation of calcitonin and parathyroid hormone secretion by oestrogens.

J. Stevenson, 1982, Maturitas.

Spotlight on gender.

L. Mosca, P. Collins, J. Stevenson, 2002, Cardiovascular research.

CALCITONIN FOR POSTMENOPAUSAL BONE LOSS

J. Studd, M. Whitehead, J. Stevenson, 1988, The Lancet.

Action of Specific Estrogens on Vascular Cells

J. Stevenson, C. Wingrove, 1999 .

Effect of Continuous Combined Estrogen and Desogestrel Hormone Replacement Therapy on Serum Lipids and Lipoproteins

M. Whitehead, J. Stevenson, D. Crook, 1994, Obstetrics and gynecology.

Stimulation of 1,25-dihydroxycholecalciferol production by prolactin and related peptides in intact renal cell preparations in vitro.

D. Brown, I. Macintyre, J. Stevenson, 1981, Biochimica et biophysica acta.

A PHYSIOLOGICAL ROLE FOR CALCITONIN: PROTECTION OF THE MATERNAL SKELETON

M. Whitehead, I. Macintyre, J. Stevenson, 1979, The Lancet.

Long-term benefits and risks of HRT (Section 11): Cardiovascular disease

J. Stevenson, 2016, Post reproductive health.

Transdermal administration of oestrogen/progestagen hormone replacement therapy

M. Whitehead, J. Stevenson, D. Crook, 1990, The Lancet.

Increased concentration of circulating calcitonin gene related peptide during normal human pregnancy.

J. Stevenson, R. Warren, D. Macdonald, 1986, British medical journal.

Pathogenesis, Prevention, and Treatment of Osteoporosis

J. Stevenson, 1990, Obstetrics and gynecology.

4 Osteoporosis: pathogenesis and risk factors

J. Stevenson, 1988 .

Etiology of postmenopausal osteoporosis

J. Stevenson, 1986 .

Calcium absorption in rheumatoid arthritis.

P. Sambrook, J. Reeve, B. Ansell, 1985, Annals of the rheumatic diseases.

Hormone Replacement Therapy

M. Whitehead, J. Stevenson, M. Ellerington, 1991, Journal of the Royal Society of Medicine.

EFFECT OF CALCITONIN ON GASTROINTESTINAL REGULATORY PEPTIDES IN MAN

T. Adrian, S. Bloom, J. Stevenson, 1985, Clinical endocrinology.

Measuring body fat.

B. Lees, J. Stevenson, C. Walton, 1996, The American journal of medicine.

Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

S. Anker, I. Godsland, A. Coats, 1997, Journal of the American College of Cardiology.

Effect of rifampicin and isoniazid on vitamin D metabolism

M. Brodie, A. Boobis, B. K. Park, 1982, Clinical pharmacology and therapeutics.

Interrelation of oestrogen and the major calcium regulating hormones

J. Stevenson, 1984 .

Dietary intake of calcium and postmenopausal bone loss.

T. Spinks, M. Whitehead, L. Banks, 1988, BMJ.

Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women

M. Whitehead, B. Lees, T. Hillard, 1990, The Lancet.

Optimising delivery systems for HRT.

J. Stevenson, 1999, Maturitas.

Fluid and electrolyte disorders. Calcium.

J. Stevenson, 1984, British journal of hospital medicine.

THE METABOLIC AND CARDIOVASCULAR CONSEQUENCES OF HRT

J. Stevenson, J. Stevenson, 1995, The British journal of clinical practice.

Does estrogen therapy reduce coronary artery calcification in postmenopausal women?

J. Stevenson, 2007, Nature Clinical Practice Cardiovascular Medicine.

Long-Term Effects of Oral and Transdermal Hormone Replacement Therapies on Serum Lipid and Lipoprotein Concentrations

M. Whitehead, J. Stevenson, D. Crook, 1994, Obstetrics and gynecology.

On the route to combined evidence from OC and HRT/ERT.

J. Jespersen, C. Kluft, G. Lowe, 2002, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Iron and coronary heart disease. Control for haematological variables.

I. Godsland, J. Stevenson, R. Bruce, 1993, BMJ.

Management of premature menopause

J. Williamson, M. Rees, J. Stevenson, 2007, Menopause international.

Hormonal Management of Osteoporosis during the Menopause

N. Panay, J. Stevenson, G. Kovacs, 2020, Managing the Menopause.

The Medical Management of Hypercalcaemia

J. Stevenson, J. Swan, 1993 .

Regular Re viezv Postmenopausal osteoporosis

R. Hay, J. Stevenson, 2006 .

The Role of Hormone Replacement Therapy in the Prevention and Treatment of Osteoporosis

M. Whitehead, J. Stevenson, M. Ellerington, 1994 .

Calcium and postmenopausal bone loss: Authors' reply

M. Whitehead, J. Stevenson, 1988 .

CALCIUM SUPPLEMENTS AND POSTMENOPAUSAL OSTEOPOROSIS

B. Nordin, I. Macintyre, J. Stevenson, 1985, The Lancet.

PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS

I. Macintyre, J. Stevenson, 1985, The Lancet.

Handling hormone replacement therapy: key issues for the prescriber.

J. Stevenson, 1996, European journal of obstetrics, gynecology, and reproductive biology.

17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells.

I. Godsland, E. Garr, J. Stevenson, 1998, Biochimica et biophysica acta.

Current Management of Malignant Hypercalcaemia

J. Stevenson, 1988, Drugs.

Oestrogen replacement after oophorectomy.

M. Whitehead, J. Stevenson, T. Hillard, 1992, BMJ.

Where has WHI led us now?

J. Stevenson, 2004, Maturitas.

Long-term effects of hormone replacement therapy

J. Stevenson, 2003, The Lancet.

Sipple syndrome: marked variability of the disease within a family and implications for management.

I. Macintyre, J. Stevenson, J. Lynn, 1981, Postgraduate medical journal.

Regional and total skeletal measurements in the early postmenopause.

T. Spinks, M. Whitehead, G. Lane, 1987, The Journal of clinical investigation.

Thiazide diuretics, β-blockers, and coronary heart disease

V. Wynn, J. Stevenson, R. Bruce, 1990, The Lancet.

Malignant hypercalcaemia.

J. Stevenson, J. Stevenson, 1985, British medical journal.

Mild asymptomatic hyperparathyroidism.

J. Stevenson, J. Lynn, 1980, British medical journal.

Selection Bias in HRT Epidemiology

M. Whitehead, J. Stevenson, DavidF. Ross, 1996 .

Non-estrogen-based treatments for menopausal symptoms

J. Williamson, M. Rees, J. Stevenson, 2008, Menopause international.

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).

C. Cooper, J. Reginster, R. Rizzoli, 2014, Maturitas.

Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.

S. Anker, I. Godsland, T. Chua, 1997, European heart journal.

Cardiac arrhythmias following successful surgical closure of atrial septal defect.

J. Reid, J. Stevenson, 1967, British heart journal.

The menopausal hot flush: a review

P. Maki, M. Hunter, J. Stevenson, 2017, Climacteric : the journal of the International Menopause Society.

Paget's disease of bone : the effect of stopping long term human calcitonin and recommendations for future treatment

J. Pennock, F. Doyle, L. Banks, 1980 .

European Consensus Development Conference on menopause

T. Spector, C. Christiansen, J. Kanis, 1996 .

Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women

M. Whitehead, J. Stevenson, N. Shennan, 1987, British medical journal.

A woman's journey through the reproductive, transitional and postmenopausal periods of life: impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement.

J. Stevenson, 2011, Maturitas.

Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety.

N. Panay, J. Stevenson, C. Pexman-Fieth, 2013, Maturitas.

Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram.

I. Godsland, J. Stevenson, D. Crook, 1994, Journal of the American College of Cardiology.

Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.

W. Mack, H. Hodis, R. Lobo, 2016, Atherosclerosis.

Hormone replacement therapy: risks and benefits.

J. Stevenson, S. Whitcroft, 1992, Clinical endocrinology.

Association between age at menopause and fracture risk: a systematic review and meta-analysis

I. Lambrinoudaki, D. Goulis, E. Tsiridis, 2018, Endocrine.

The Metabolic Syndrome

F. Leyva, J. Stevenson, 1999 .

Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options

I. Lambrinoudaki, D. Goulis, S. Karras, 2016, International journal of clinical practice.

Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS).

I. Lambrinoudaki, Y. Schouw, T. Simoncini, 2016, Maturitas.

Mild asymptomatic hyperparathyroidism.

J. Stevenson, J. Lynn, 1980, British medical journal.

Time to end a conservative treatment for mild hyperparathyroidism

J. Stevenson, J. Lynn, 1988, British medical journal.

Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins.

V. Wynn, M. Whitehead, T. Hillard, 1992, American journal of obstetrics and gynecology.

Danazol induces resistance to both insulin and glucagon in young women.

I. Godsland, V. Wynn, M. Ghatei, 1992, Clinical science.

Menopausal Hormone Therapy and Type 2 Diabetes Prevention: Evidence, Mechanisms, and Clinical Implications

J. Manson, V. Fonseca, F. Mauvais-Jarvis, 2017, Endocrine reviews.

Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies

S. Shapiro, H. Burger, A. Mueck, 2013, Journal of Family Planning and Reproductive Health Care.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

S. Shapiro, H. Burger, A. Mueck, 2012, Journal of Family Planning and Reproductive Health Care.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

S. Shapiro, A. Mueck, R. Farmer, 2012, Journal of Family Planning and Reproductive Health Care.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

S. Shapiro, A. Mueck, R. Farmer, 2011, Journal of Family Planning and Reproductive Health Care.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

S. Shapiro, A. Mueck, R. Farmer, 2011, Journal of Family Planning and Reproductive Health Care.

Hyperleptinaemia in chronic heart failure. Relationships with insulin.

S. Anker, W. Kox, K. Egerer, 1998, European heart journal.

17 b-Oestradiol inhibits stimulated endothelin release in human vascular endothelial cells

J. Stevenson, C. Wingrove, 1997 .

Interventions for Osteoporosis

J. Stevenson, F. Keating, 2007 .

Primary Prevention of Cardiovascular Disease with HRT

J. Stevenson, K. Maclaran, 2012, Women's health.

Dependence and oestrogen replacement

P. Hardiman, J. Studd, M. Whitehead, 1992, The Lancet.

Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.

S. Anker, W. Kox, A. Coats, 1997, Heart.

[Management of cardiovascular risk in the peri-menopausal woman--a consensus statement of European cardiologists and gynaecologists].

T. Simon, R. Kaaja, M. Stramba-Badiale, 2007, Kardiologia polska.

Management of cardiovascular risk in the perimenopausal women: a consensus statement of European cardiologists and gynecologists

T. Simon, R. Kaaja, M. Stramba-Badiale, 2007, Climacteric : the journal of the International Menopause Society.

BMS consensus statement for primary prevention of coronary heart disease in women

J. Stevenson, 2019, Post reproductive health.

Primary prevention of coronary heart disease in women

M. Rees, J. Stevenson, 2008, Menopause international.

Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women.

I. Godsland, M. Whitehead, J. Stevenson, 2002, Maturitas.

Prevention of cardiovascular disease in women: evidence for the use of hormone replacement therapy

M. Flather, P. Collins, B. Lees, 2001 .

Developments in computerized axial tomography scanning and its use in bone disease measurement

L. Banks, J. Stevenson, 1990 .

Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease.

G. Rosano, I. Godsland, P. Collins, 1995, The Journal of clinical endocrinology and metabolism.

Hormone Replacement Therapy and the Cardiovascular System

I. Godsland, M. Whitehead, P. Collins, 2012, Drugs.

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

I. Godsland, V. Wynn, M. Whitehead, 1993, Metabolism: clinical and experimental.

Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age.

B Lees, I. Godsland, C Walton, 1995, The American journal of medicine.

Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists

I. Lambrinoudaki, G. Rosano, A. Maas, 2021, European heart journal.

A Pooled Analysis of the Effects of Conjugated Estrogens/Bazedoxifene on Lipid Parameters in Postmenopausal Women From the Selective Estrogens, Menopause, and Response to Therapy (SMART) Trials.

A. Chines, K. Ryan, K. Pan, 2015, The Journal of clinical endocrinology and metabolism.

Dyslipidemia is a well‐recognized cardiovascu‐ lar risk factor and the menopausal transition is associated with adverse changes to women’s lipid profiles, with increases in total and low‐density lipoprotein (LDL) cholesterol and reductions in high‐density lipoprotein (HDL) cholesterol

J. Stevenson, K. Maclaran, 2016 .

The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits – an attempt to interpret the Women's Health Initiative results

J. Stevenson, H. Kuhl, 2006, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Hormone therapy for first-line management of menopausal symptoms: Practical recommendations

A. Graziottin, J. Stevenson, S. Palacios, 2019, Women's health.

Management of male osteoporosis: report of the UK Consensus Group.

C. Cooper, R. Francis, R. Eastell, 1998, QJM : monthly journal of the Association of Physicians.

Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference

P. Stute, S. Maffei, J. Stevenson, 2020, Drugs in context.

Sex- and menopause-associated changes in body-fat distribution.

B. Lees, J. Stevenson, C. Ley, 1992, The American journal of clinical nutrition.

Independent relationships between bone mineral density, regional body fat and insulin sensitivity in white males

I. Godsland, W. Loh, J. Stevenson, 2019, Clinical endocrinology.

Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.

I. Godsland, J. Stevenson, D. Crook, 2005, The Journal of clinical endocrinology and metabolism.

Erythrocyte-derived measures of membrane lipid composition in healthy men: associations with arachidonic acid at low to moderate but not high insulin sensitivity.

I. Godsland, J. Stevenson, C. Felton, 2004, Metabolism: clinical and experimental.

Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.

I. Godsland, M. Whitehead, J. Stevenson, 2000, Metabolism: clinical and experimental.

Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease.

P. McKeigue, I. Godsland, N. Chaturvedi, 2000, Metabolism: clinical and experimental.

Relationships between insulin metabolism, serum lipid profile, body fat distribution and blood pressure in healthy men.

I. Godsland, B. Lees, J. Stevenson, 1995, Atherosclerosis.

Insulin resistance syndrome in postmenopausal women with cardiological syndrome X.

P. Poole‐Wilson, G. Rosano, I. Godsland, 1995, British heart journal.

SERUM-PROLACTIN AFTER SUBCUTANEOUS HUMAN CALCITONIN

J. Stevenson, K. Colston, K. Mashiter, 1977, The Lancet.

The glycolytic pathway to coronary heart disease: a hypothesis.

I. Godsland, F. Leyva, J. Stevenson, 1998, Metabolism: clinical and experimental.

Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.

I. Godsland, M. Oliver, J. Stevenson, 1994, British heart journal.

Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study.

I. Godsland, F. Leyva, J. Stevenson, 2004, International journal of cardiology.

Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.

A. Pines, F. al-Azzawi, D. Barlow, 2005, Maturitas.

Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?

C. Cooper, R. Francis, R. Eastell, 2001, QJM : monthly journal of the Association of Physicians.

Author's reply

J. Stevenson, 2005 .

A model of care for healthy menopause and ageing: EMAS position statement.

I. Lambrinoudaki, Y. T. van der Schouw, T. Simoncini, 2016, Maturitas.

Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements.

I. Godsland, J. Stevenson, A. Proudler, 1994, Metabolism: clinical and experimental.

The True Risks of HRT

J. Stevenson, 2018 .

Elevated serum lipoprotein(a) levels in young women with endometriosis.

D. Edmonds, J. Stevenson, D. Crook, 1995, Metabolism: clinical and experimental.

Osteoporosis: Questions and Answers

J. Stevenson, M. Ellerington, 1993 .

HRT use: where do we stand today?

J. Stevenson, 1996, The British journal of clinical practice.

Altered calcitonin gene in a young patient with osteoporosis.

M. Alevizaki, S. Legon, S. Girgis, 1989, BMJ.

Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate

Farook Al-Azzawi, Belinda Lees, John Thompson, 2005, Menopause.

Long-term benefits and risks of HRT (Section 11): Osteoporosis

J. Stevenson, 2016, Post reproductive health.

Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.

I. Godsland, J. Stevenson, D. Crook, 1993, Contraception.

Preliminary evaluation of a new ultrasound bone densitometer

B. Lees, J. Stevenson, 1993, Calcified Tissue International.

Osteoporosis after 60

R. Lindsay, M. Whitehead, C. Christiansen, 1990, BMJ.

Calcium supplementation of the diet.

J. Stevenson, 1989, BMJ.

Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.

I. Godsland, S. Bloom, F. Leyva, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Hyperleptinemia as a Component of a Metabolic Syndrome of Cardiovascular Risk

I. Godsland, S. Bloom, M. Ghatei, 1998 .

Metabolic consequences of the menopause

J. Stevenson, 2007 .

HRT and breast cancer: a million women ride again

R. Farmer, J. Stevenson, 2020, Climacteric : the journal of the International Menopause Society.

Cardiovascular health and the menopause, metabolic health.

J. Stevenson, P. Anagnostis, 2023, Best practice & research. Clinical endocrinology & metabolism.

The effect of menopause on serum uric acid levels in non-obese healthy women.

J. Stevenson, C. Wingrove, C. Walton, 1998, Metabolism: clinical and experimental.

Adiposity Measurements by BMI, Skinfolds and Dual Energy X-Ray Absorptiometry in relation to Risk Markers for Cardiovascular Disease and Diabetes in Adult Males

I. Godsland, D. Johnston, J. Stevenson, 2013, Disease markers.

DIETARY CALCIUM AND HIP FRACTURE

J. Stevenson, 1988, The Lancet.

Misrepresentation of the risk of ovarian cancer among women using menopausal hormones. Spurious findings in a meta-analysis.

S. Shapiro, A. Mueck, R. Baber, 2015, Maturitas.

Aspirin in the primary prevention of cardiovascular disease.

J. Stevenson, Colin F Galloway, 2011, Maturitas.

EMAS recommendations for conditions in the workplace for menopausal women.

I. Lambrinoudaki, A. Griffiths, Y. T. van der Schouw, 2016, Maturitas.

Practical recommendations for hormone replacement therapy in the peri- and postmenopause

H. Burger, T. Maudelonde, A. Genazzani, 2004, Climacteric : the journal of the International Menopause Society.

Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism

I. Godsland, M. Whitehead, J. Stevenson, 2013, Clinical endocrinology.

Vertebral CT scanning.

L. Banks, J. Stevenson, 1986, Scottish medical journal.

Modernizing the NHS: observations and recommendations from the British Menopause Society

M. Savvas, J. Studd, J. Robinson, 2011, Menopause international.

Sex Steroids' Effects on Brain, Heart and Vessels

T. Simoncini, A. Genazzani, R. Brinton, 2019, ISGE Series.

Committee's action will undermine further research and development

I. Godsland, V. Wynn, J. Stevenson, 1995, BMJ.

Bone-density measurement.

J. Kanis, C. Christiansen, J. Stevenson, 1992, Lancet.

Osteomalacia presenting as pathological fractures during pregnancy in Asian women of high social class

J. Stevenson, 1985 .

The effects of the menopause on insulin sensitivity, secretion and elimination in non‐obese, healthy women

I. Godsland, V. Wynn, J. Stevenson, 1993, European journal of clinical investigation.

CALCITONIN SECRETION AND POSTMENOPAUSAL OSTEOPOROSIS

M. Whitehead, J. Stevenson, 1982, The Lancet.

SEX, RACE, AGE, AND SERUM-CALCITONIN

J. Stevenson, C. Hillyard, 1979, The Lancet.

The Prevention of Osteoporosis Using Sequential Low-Dose Hormone Replacement Therapy with Estradiol-17β and Dydrogesterone

B. Lees, J. Stevenson, J. C. Stevenson, 2001, Osteoporosis International.

Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow‐up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC‐1)

Worthington, I. Godsland, J. Stevenson, 1998, Journal of internal medicine.

NICE guideline – Menopause : diagnosis and management

J. Stevenson, 2016 .

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies

S. Shapiro, A. Mueck, R. Farmer, 2011, Journal of Family Planning and Reproductive Health Care.

Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.

S. Shapiro, H. Burger, A. Pines, 2014, Journal of the National Cancer Institute.

Estrogen receptors and human bone cells: Immunocytochemical studies

T. Arnett, R. King, J. Hayward, 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Modified Method of Spinal Computed Tomography for Trabecular Bone Mineral Measurements

L M Banks, J C Stevenson, L. Banks, 1986, Journal of computer assisted tomography.

Insulin resistance and cigarette smoking

I. Godsland, V. Wynn, J. Stevenson, 1992, The Lancet.

A randomized comparative study of the metabolic effects of two regimens of gestrinone in the treatment of endometriosis.

R. Shaw, B. Lees, J. Stevenson, 1993, Fertility and sterility.

Oral versus transdermal hormone replacement therapy.

I. Godsland, M. Whitehead, B. Lees, 1993, International journal of fertility and menopausal studies.

Differences in proximal femur bone density over two centuries

T. Arnett, B. Lees, J. Stevenson, 1993, The Lancet.

Current management of pelvic organ prolapse in aging women: EMAS clinical guide.

I. Lambrinoudaki, D. Goulis, P. Chedraui, 2018, Maturitas.